Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2025 19:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology...
September 03, 2025 16:30 ET | Source: Myriad Genetics, Inc.

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new...
August 27, 2025 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will...
August 18, 2025 08:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Appoints Ben Wheeler Chief Financial Officer

SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been...
August 13, 2025 08:00 ET | Source: Myriad Genetics, Inc.

New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results

SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today released findings from its latest...
August 05, 2025 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum

Myriad Genetics announced financial results for its second quarter ended June 30, 2025, updated full-year 2025 financial guidance on business performance.
July 31, 2025 08:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces New $200 Million Credit Facility

SALT LAKE CITY, July 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has closed a five-year...
July 29, 2025 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025

SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings...
July 15, 2025 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Earns 2025 Great Place To Work Certification™

SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has received the Great...
June 03, 2025 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen

Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for paternal testingEarly access via large-scale clinical study to establish the...